22 results on '"Fu, Edouard L."'
Search Results
2. A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes
3. Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study
4. Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study
5. Long-term Visit-to-Visit Variability in Hemoglobin A1c and Kidney-Related Outcomes in Persons With Diabetes
6. A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality
7. Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants
8. Risk of Acute Kidney Injury Among Older Adults With Heart Failure and With Reduced Ejection Fraction Treated With Angiotensin-Neprilysin Inhibitor vs Renin-Angiotensin System Inhibitor in Routine Clinical Care
9. Discordances Between Creatinine and Cystatin C–Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice
10. Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations
11. Association between cholinesterase inhibitors and kidney function decline in patients with Alzheimer’s dementia
12. Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice
13. Patient-Reported Measures and Lifestyle Are Associated With Deterioration in Nutritional Status in CKD Stage 4-5: The EQUAL Cohort Study
14. Kidney Function, Kidney Replacement Therapy, and Mortality in Men and Women
15. GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
16. Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes
17. Incorporation of Cystatin C Testing in Clinical Practice: Real World Experience in Sweden
18. Estimating the prevalence of chronic kidney disease while accounting for nonrandom testing with inverse probability weighting
19. Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
20. WCN24-255 Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
21. Routine care data and the benefits of GLP1 receptor agonists on slowing kidney function decline
22. Interpreting Nonrandomized Evidence for Clinical Decision Making in Cardio-Oncology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.